Lineage Cell Therapeutics...

AMEX: LCTX · Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.21
1.68%
After-hours: Aug 15, 2025, 04:11 PM EDT

Lineage Cell Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.41 -8.76 -7.54 -9.37
PEG Ratio
0.24 0.44 0.18 -0.11
PS Ratio
10.59 21.04 13.51 103.45
PB Ratio
1.28 2.97 2.71 4.37
P/FCF Ratio
-4.25 -6.44 307.52 -16.85
P/OCF Ratio
-4.36 -6.59 187.59 -17.11
OCF/S Ratio
-2.43 -3.19 0.07 -6.05
Debt / Equity Ratio
0.03 0.05 0.05 0.03
Quick Ratio
3.65 2.14 3.16 2.37
Current Ratio
3.65 2.14 3.16 2.37
Asset Turnover
0.08 0.09 0.12 0.02
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.24 -0.34 -0.36 -0.47
Return on Assets
-0.16 -0.21 -0.21 -0.25
Return on Invested Capital
-0.21 -0.27 -0.22 -0.34
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.96 0.92 0.95 0.63
Net Profit Margin
-1.96 -2.4 -1.79 -11.04
Pretax Profit Margin
-1.96 -2.6 -1.76 -11.11
Operating Profit Margin
-2.26 -2.77 -1.53 -12.63
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.2 -2.69 -1.48 -12.41